UM  > 中華醫藥研究院
Development of small-sized PPD nanocrystals to improve oral bioavailability and brain drug delivery
Chen Chen1; Lisha Wang2; Fangrui Cao2; Xiaoqing Miao1; Qi Chang2; Ying Zheng1
2016-02
Source PublicationNanomedicine: Nanotechnology, Biology, and Medicine
ISSN1549-9634
Volume12Issue:2Pages:497-498
Other Abstract

Nowadays drug delivery to the brain remains a challenge, which is mainly due to the complex tight junctions and selective characteristics of the blood–brain barrier. The aim of the study was to fabricate PPD nanocrystals to improve its oral bioavailability and delivery into the brain. Protopanaxadiol (PPD) is a Darma alkanes tetracyclic triterpene with poor solubility (< 50 ng/ml) and high lipophilicity. PPD exhibits strong anti-cancer activity and antidepressant-like effect, whereas its poor aqueous solubility limits its application. In this study, single factor experiment, including various type of solvents and stabilizers, drug concentration, organic/aqueous solvent ratio and stirring time, was used to study their effects on particle size, polydispersity index (PdI), zeta potential and short-term stability. The PPD nanocrystals were prepared using anti-solvent precipitation where d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) was optimized as the stabilizer. The formulation was consisting of 0.5 mg/ml drug, PPD/TPGS at 3:1, and Mill-Q water/acetone at 10:1, and particle size, PdI and zeta potential of the PPD nanocrystals were 90.44 ± 1.45 nm, 0.149 ± 0.016 and − 21.2 ± 0.85 mV, respectively. The fabricated nanocrystals were nearly spherical with uniform size distribution observed by transmission electron microscope. Powder X-ray diffraction analysis indicates that PPD was present in a crystalline state in the nanocrystals. In-vitro stability study showed that PPD nanocrystals can be stabilized at 4 °C for one month. In in-vitro dissolution experiment, more than 70% PPD could be rapidly released from nanocrystals within 3 min in 0.2% (w/v) sodium lauryl sulfate at 37 ± 0.5 °C. After oral administration, PPD nanocrystals were absorbed quickly into plasma with a Tmax of 0.70 h, and the plasma Cmax values of PPD nanocrystals were 4.75-fold higher than that of the physical mixture. Oral bioavailability of PPD nanocrystals (AUCall) was 18.1-fold superior than the physical mixture. Interestingly, there was about 1 h delay for PPD to reach to Tmax in the brain than that in the plasma, which was eliminated slowly than those in the plasma. The results suggested that PPD was rapidly absorbed into plasma, then transported across the BBB and eliminated in the brain slowly. The intracerebral Cmax values of PPD nanocrystals were 2.42-fold higher than that of the physical mixture. In summary, the small-sized PPD nanocrystals may be a potential oral delivery system to enhance PPD's poor bioavailability and its delivery into the brain for neurodegeneration disease and brain cancer therapy.

DOIhttps://doi.org/10.1016/j.nano.2015.12.146
Indexed BySCI
Language英语
WOS Research AreaScience & Technology - Other Topics ; Research & Experimental Medicine
WOS SubjectNanoscience & Nanotechnology ; Medicine, Research & Experimental
WOS IDWOS:000373923400163
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Corresponding AuthorYing Zheng
Affiliation1.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, China
2.Chinese Academy of Medical Sciences, Peking Union Medical College, Institute of Medicinal Plant Development, Beijing, China
First Author AffilicationInstitute of Chinese Medical Sciences
Corresponding Author AffilicationInstitute of Chinese Medical Sciences
Recommended Citation
GB/T 7714
Chen Chen,Lisha Wang,Fangrui Cao,et al. Development of small-sized PPD nanocrystals to improve oral bioavailability and brain drug delivery[J]. Nanomedicine: Nanotechnology, Biology, and Medicine,2016,12(2):497-498.
APA Chen Chen,Lisha Wang,Fangrui Cao,Xiaoqing Miao,Qi Chang,&Ying Zheng.(2016).Development of small-sized PPD nanocrystals to improve oral bioavailability and brain drug delivery.Nanomedicine: Nanotechnology, Biology, and Medicine,12(2),497-498.
MLA Chen Chen,et al."Development of small-sized PPD nanocrystals to improve oral bioavailability and brain drug delivery".Nanomedicine: Nanotechnology, Biology, and Medicine 12.2(2016):497-498.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Chen Chen]'s Articles
[Lisha Wang]'s Articles
[Fangrui Cao]'s Articles
Baidu academic
Similar articles in Baidu academic
[Chen Chen]'s Articles
[Lisha Wang]'s Articles
[Fangrui Cao]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Chen Chen]'s Articles
[Lisha Wang]'s Articles
[Fangrui Cao]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.